2024 ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) REPORT
Extracted ESG KPIs
KPIs are organized by ESG aspects.
The types of emissions and respective emissions data.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Ammonia Nitrogen | ton | 0.3092 | 49 |
| Chemical Oxygen Demand (COD) | ton | 4.53 | 49 |
| Nitrogen Oxides (NOx) Emissions | ton | 0.3 | 49 |
| Particulate Matter (PM) Emissions | ton | 0.009 | 49 |
| Sulfur Oxides (SOx) Emissions | ton | 0.033 | 49 |
| Total waste gas Emissions | ton | 0.43 | 49 |
| Volatile Organic Compounds (VOCs) Emissions | ton | 0.09 | 49 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Including: Scope 1 GHG Emissions | tCO₂e | 5307.75 | 49 |
| Including: Scope 2 GHG Emissions | tCO₂e | 21493 | 49 |
| Total GHG Emissions | tCO₂e | 26800.75 | 49 |
| Total GHG emissions (Scope 1 + Scope 2) | tCO2e | 26800.75 | 8 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Dangerous Waste Density | ton/ RMB 1000000 revenue | 0.0869 | 49 |
| Dangerous waste handled | tons | 169.31 | 8 |
| Total Wastewater Discharges | ton | 122714 | 49 |
| Total dangerous Waste | ton | 169.31 | 49 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| General Waste Density | ton/ RMB 1000000 revenue | 0.084 | 49 |
| Total general Waste | ton | 163.74 | 49 |
Description of emissions target(s) set and steps taken to achieve them.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Consumption of Packaging Materials | ton | 28.94 | 34, 49 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Comprehensive Energy Consumption | tce | 9702.17 | 34, 48 |
| Direct Energy Consumption | tce | 4999.5 | 34, 49 |
| Energy Usage Intensity | tce/RMB 1000000 revenue | 4.98 | 34, 49 |
| Including: Electricity | MWh | 38264.2 | 49 |
| Including: Gasoline | ton | 107.25 | 49 |
| Including: Giesel | Liters | 951.93 | 49 |
| Including: Natural Gas | m³ | 3639460 | 49 |
| Indirect Energy Consumption | tce | 4702.67 | 34, 49 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Total Water Consumption | ton | 416929 | 34, 49 |
| Water Resource Usage Intensity | ton/ RMB 1000000 revenue, ton/RMB 1000000 revenue | 213.99 | 34, 49 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Annual Total Investment in Environmental Protection | 10000 yuan, RMB 10000 | 423.55 | 33, 48 |
| First Prize of Shanghai Digital Intelligence Manufacturing Solution Innovation Competition (Engineering) | prize | 1 | 6 |
| Investment in environmental protection | million RMB | 4.2355 | 8 |
| Number of Environmental Protection Trainings | Times | 11 | 33 |
| Number of Environmental Protection Trainings in the Year | Times | 11 | 48 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Average Attendance Rate at Meetings of the Board of Directors | % | 100 | 48 |
| Employees Working in Hong Kong, Macau, and Taiwan | Persons, persons | 1 | 42, 50 |
| Employees Working in other countries | Persons, persons | 29 | 42, 50 |
| Employees Working in the Chinese Mainland | Persons, persons | 2548 | 42, 50 |
| Including: Number of Executive Directors | Persons | 8 | 48 |
| Including: Number of Female Directors | Persons | 4 | 48 |
| Including: Number of Independent Directors | Persons | 5 | 48 |
| Number of All Members of the Board of Directors | Persons | 14 | 48 |
| Number of Board of Directors meetings held | 13 | 7 | |
| Number of Employees Aged 30 and below | Persons, persons | 777 | 42, 50 |
| Number of Employees Aged 31 to 49 | Persons, persons | 1718 | 42, 50 |
| Number of Employees Aged 50 and above | Persons, persons | 83 | 42, 50 |
| Number of Employees under Labor Contracts | Persons, persons | 2566 | 42, 50 |
| Number of Ethnic Minority Employees | Persons, persons | 71 | 42, 50 |
| Number of Female Employees | Persons, persons | 1350 | 42, 50 |
| Number of Male Employees | Persons, persons | 1228 | 42, 50 |
| Others (Employment Type) | Persons | 12 | 50 |
| Percentage of female directors on Board | % | 29 | 7 |
| Percentage of female employees | % | 52.4 | 8 |
| Total Number of Employees | Persons, persons | 2578 | 42, 50 |
Employee turnover rate by gender, age group and geographical region.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Employee Turnover Rate | % | 19.66 | 42, 50 |
| Female Employee Turnover Rate | % | 17.83 | 50 |
| Male Employee Turnover Rate | % | 21.58 | 50 |
| Turnover Rate of Employees Aged 30 and below | % | 22.3 | 50 |
| Turnover Rate of Employees Aged 31 to 49 | % | 18.85 | 50 |
| Turnover Rate of Employees Aged 50 and above | % | 9.78 | 50 |
| Turnover Rate of Employees Working in other countries | % | 12.12 | 51 |
| Turnover Rate of Employees Working in the Chinese Mainland | % | 19.75 | 51 |
Lost days due to work injury.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Days Lost Due to Work Injury | Day | 49 | 51 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Coverage of Occupational Health Checkups | % | 100 | 51 |
| Coverage of Safety Production Training | % | 100 | 51 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Coverage of pharmacovigilance training for employees | 100% | 7 | |
| Employee Training Coverage | % | 100 | 51 |
| Number of research outcomes of toripalimab selected for oral reports at the 27th National Clinical Oncology Conference and the 2024 CSCO Academic Annual Meeting | oral reports | 7 | 24 |
| Number of research results of toripalimab presented at the 66th Annual Meeting of the American Society for Radiation Oncology (ASTRO) | research results | 6 | 24 |
| Pharmacovigilance Training Coverage Rate | % | 100 | 49 |
| R&D investment | billion RMB | 1.275 | 7 |
| Total Number of Participants in Pharmacovigilance Training | Persons | 2743 | 50 |
| Work safety training coverage | 100% | 8 |
The average training hours completed per employee by gender and employee category.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Average Training Hours of Female Employee | Hour | 53.01 | 51 |
| Average Training Hours of Male Employee | Hour | 68.91 | 51 |
| Average Training Hours of Senior Management | Hour | 22.64 | 51 |
| Average number of training hours | Hour | 60.59 | 51 |
| Number of Employee Trainings | Sessions | 484 | 51 |
Number of suppliers by geographical region.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Including: Number of Domestic Suppliers | Unit | 2168 | 51 |
| Number of Suppliers | Unit | 2298 | 51 |
Percentage of total products sold or shipped subject to recalls for safety and health reasons.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Recall ratio | 0% | 7 |
Number of products and service related complaints received and how they are dealt with.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Disease control rate (DCR) for first-line treatment of ES-SCLC with toripalimab, surufatinib, and EP | % | 100 | 27 |
| Median overall survival (mOS) for first-line treatment of ES-SCLC with toripalimab, surufatinib, and EP | months | 21.1 | 27 |
| Median progression-free survival (mPFS) for first-line treatment of ES-SCLC with toripalimab, surufatinib, and EP | months | 6.9 | 27 |
| Objective response rate (ORR) for first-line treatment of extensive-stage small-cell lung cancer (ES-SCLC) with toripalimab, surufatinib, and EP | % | 97.1 | 27 |
| Tumor thrombus downstaging rate for clear cell renal cell carcinoma (RCC) with toripalimab and axitinib as neoadjuvant therapy (IVCTT) | % | 44 | 27 |
Description of practices relating to observing and protecting intellectual property rights.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Number of copyrights held | Cases | 10 | 50 |
| Number of invention patents held | Cases | 70 | 50 |
| Number of new patents added in the year | Cases | 32 | 50 |
| Number of patents held | Cases | 175 | 50 |
| Number of patents obtained | 32 | 7 | |
| Number of patents under review | Cases | 284 | 50 |
| Top 100 Chinese Pharmaceutical Innovative Enterprises | enterprises | 100 | 6 |
| Total number of patents | 175 | 7 |
Description of quality assurance process and recall procedures.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Top 10 Influential Chinese Pharmaceutical Companies Going Global | companies | 10 | 6 |
Description of preventive measures and whistle-blowing procedures, and how they are implemented and monitored.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Number of Meetings of Board of Directors | Times | 13 | 48 |
| Number of Meetings of the Audit Committee | Times | 5 | 48 |
| Number of the General Meeting of Shareholders | Times | 4 | 48 |
Description of anti-corruption training provided to directors and staff.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Number of Directors Covered by Anti-bribery and Anti-corruption Training | Persons | 14 | 48 |
| Number of Employees Covered by Anti-bribery and Anti-corruption Training | Persons | 2578 | 48 |
| Number of Meetings of the Board of Supervisors | Times | 7 | 48 |
| Number of Meetings of the Nomination Committee | Times | 5 | 48 |
| Number of Meetings of the Remuneration and Appraisal Committee | Times | 6 | 48 |
| Number of Meetings of the Strategic Committee | Times | 1 | 48 |
| Number of Senior Management Covered by Anti-bribery and Anti-corruption Training | Persons | 7 | 48 |
| Percentage of Directors Covered by Anti-bribery and Anti-corruption Training | % | 100 | 48 |
| Percentage of Employees Covered by Anti-bribery and Anti-corruption Training | % | 100 | 48 |
| Percentage of Senior Management Covered by Anti-bribery and Anti-corruption Training | % | 100 | 48 |
| Percentage of independent directors on Board | % | 36 | 7 |
Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Donation to Medicine Aid | RMB 10000 | 1107.16 | 51 |
| Number of quarterly bilingual business progress reviews produced and disseminated | 6 | 13 | |
| Number of studies of toripalimab (anti-PD-1 monoclonal antibody) and tifcemalimab (anti-BTLA monoclonal antibody) selected for presentation at the 2024 Annual Meeting of American Society of Clinical Oncology (ASCO) | studies | over 30 | 24 |
| Number of studies of toripalimab included in the 2024 Annual Meeting of the European Society for Medical Oncology (ESMO) | studies | 18 | 24 |
| Top Ten Innovative Biotechnology Cases (Toripalimab manufactured by Junshi Biosciences were launched on market in China, the United States, and Europe) | cases | 10 | 6 |
| Winner of Yangtze River Delta Intelligent Manufacturing Solution Innovation Competition (Engineering) | winner | 1 | 6 |
Resources contributed (e.g. money or time) to the focus area.
| Indicator | Unit | 2024 | Report Pages |
|---|---|---|---|
| Investment in Public Welfare | RMB 10000 | 2330.94 | 51 |
The types of emissions and respective emissions data.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Airborne Particulate Matter (PM) Emissions | ton | 0.009 |
| NOₓ Emissions | ton | 0.3 |
| SOₓ Emissions | ton | 0.033 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Direct GHG Emissions (Scope 1) | tCO₂e | 5307.75 |
| Indirect Energy Emissions (Scope 2) | tCO₂e | 21493 |
| Total GHG Emissions | tCO₂e | 26800.75 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Total Hazardous Waste | ton | 169.31 |
| Total Hazardous Waste Intensity (By Revenue) | ton/RMB 1000000 revenue | 0.0869 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Non-Hazardous Waste Disposed | ton | 163.74 |
| Total Non-Hazardous Waste Intensity (By Revenue) | ton/RMB 1000000 revenue | 0.084 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Diesel Fuel Consumption | Liters | 951.93 |
| Energy Consumption Intensity (By Revenue) | tce/RMB 1000000 revenue | 4.98 |
| Gasoline Consumption | ton | 107.25 |
| Natural Gas Consumption | m³ | 3639460 |
| Purchased Electricity | MWh | 38264.2 |
| Total Direct Energy Consumption | tce | 4999.5 |
| Total Energy Consumption | tce | 9702.17 |
| Total Indirect Energy Consumption | tce | 4702.67 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Water Consumption | ton | 416929 |
| Water Consumption Intensity (By Revenue) | ton/ RMB 1000000 revenue | 213.99 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Total Investment in Ecological Restoration | RMB | 4235500 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Number of Employees Aged 30-50 | persons | 1718 |
| Number of Employees Aged Above 50 | persons | 83 |
| Number of Employees Aged Below 30 | persons | 777 |
| Number of Employees in Hong Kong | persons | 1 |
| Number of Employees in Mainland China | persons | 2548 |
| Number of Employees in Overseas | persons | 29 |
| Number of Female Employees | persons | 1350 |
| Number of Male Employees | persons | 1228 |
| Number of Total Employees | persons | 2578 |
| Percentage of Employees Aged 30-50 | % | 66.6 |
| Percentage of Employees Aged Above 50 | % | 3.2 |
| Percentage of Employees Aged Below 30 | % | 30.1 |
| Percentage of Female Employees | % | 52.4 |
| Percentage of Male Employees | % | 47.6 |
Employee turnover rate by gender, age group and geographical region.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Turnover Rate of Employees Aged 30-50 | % | 18.85 |
| Turnover Rate of Employees Aged Above 50 | % | 9.78 |
| Turnover Rate of Employees Aged Below 30 | % | 22.3 |
| Turnover Rate of Employees in Mainland China | % | 19.75 |
| Turnover Rate of Employees in Overseas | % | 12.12 |
| Turnover Rate of Female Employees | % | 17.83 |
| Turnover Rate of Male Employees | % | 21.58 |
| Turnover Rate of Total Employees | % | 19.66 |
Lost days due to work injury.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Lost Days Due to Work-related Injuries | Day | 49 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Health Check Coverage for Employees | % | 100 |
| Participation Rate of Safety Training | % | 100 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Percentage of Employees Trained | % | 100 |
The average training hours completed per employee by gender and employee category.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Average Training Hours (Female) | Hour | 53.01 |
| Average Training Hours (Male) | Hour | 68.91 |
| Average Training Hours (Senior Management) | Hour | 22.64 |
| Average Training Hours per Employee | Hour | 60.59 |
Number of suppliers by geographical region.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Number of Local Suppliers | Unit | 2168 |
| Number of Total Suppliers | Unit | 2298 |
Description of practices relating to observing and protecting intellectual property rights.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Number of Intellectual Property Rights Obtained by the Company | 32 | |
| Number of Invention Patents | Cases | 70 |
| Number of Patents Granted | 32 | |
| Number of Patents Held | Cases | 175 |
Description of anti-corruption training provided to directors and staff.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Anti-corruption Training Coverage among Directors and Management | % | 100 |
| Coverage Rate of Ethical Standards and Anti-Corruption Training | % | 100 |
| Coverage of Anti-corruption Training for Employees | % | 100 |
| Number of Directors and Management Attendance for Anti-corruption Training | Persons | 21 |
| Number of General Employees Attendance for Anti-corruption Training | Persons | 2578 |
| Number of People Participated in Ethical Standards and Anti-corruption Training | Persons | 2599 |
Resources contributed (e.g. money or time) to the focus area.
| Standard Indicator | Unit | 2024 |
|---|---|---|
| Total Public Welfare Donations | RMB 10000 | 2330.94 |
| Total Social Investment | RMB 10000 | 2330.94 |